Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | |
| Sales | 83,494 |
| Cost of Goods | 30,102 |
| Gross Profit | 53,392 |
| Operating Expenses | 40,542 |
| Operating Income | 12,952 |
| Interest Expense | 241 |
| Other Income | 3,890 |
| Pre-tax Income | 16,601 |
| Income Tax | 5,129 |
| Net Income Continuous | 11,472 |
| Net Income | $11,472 |
| EPS Basic Total Ops | 0.61 |
| EPS Basic Continuous Ops | 0.61 |
| EPS Diluted Total Ops | 0.56 |
| EPS Diluted Continuous Ops | 0.56 |
| EBITDA(a) | $14,819 |